Aspyra Inc. (APYI)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Aspyra Inc. (APYI) with AI Score 52/100 (Hold). Aspyra Inc. provides healthcare products and services, including software and hardware solutions, for the laboratory and imaging marketplaces. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 18, 2026Aspyra Inc. (APYI) Healthcare & Pipeline Overview
Aspyra Inc. delivers engineered workflow solutions, encompassing software, hardware, and professional services, to the healthcare sector, specifically targeting labs, clinics, and imaging centers. Founded in 1978, the company focuses on providing integrated solutions for laboratory and imaging workflows, operating within a competitive healthcare IT landscape.
Investment Thesis
Aspyra Inc. presents a focused play within the healthcare information services sector, offering specialized workflow solutions for labs and imaging centers. While the company's small market capitalization and OTC listing introduce inherent risks, its established presence since 1978 suggests a degree of stability. Key value drivers include the potential for increased adoption of its integrated software and hardware solutions by healthcare providers seeking to improve operational efficiency. However, the company's negative profit margin of -60.9% raises concerns about its financial sustainability. The beta of -51.48 indicates an inverse correlation with the market, which may offer diversification benefits but also reflects potential business-specific risks. Investors should closely monitor Aspyra's ability to achieve profitability and manage its cost structure.
Based on FMP financials and quantitative analysis
Key Highlights
- Aspyra Inc. operates in the healthcare information services sector, providing specialized workflow solutions for labs and imaging centers.
- The company was founded in 1978, indicating a long-standing presence in the healthcare IT market.
- Aspyra's solutions include software, interfaces, hardware, and professional services, offering an integrated approach to healthcare workflows.
- The company serves a diverse clientele, including specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices.
- Aspyra Inc. has a negative profit margin of -60.9%, highlighting the need for improved financial performance.
Competitors & Peers
Strengths
- Long-standing presence in the healthcare IT market.
- Integrated solutions encompassing software, hardware, and services.
- Focus on specialized laboratory and imaging workflows.
- Established customer base across various healthcare settings.
Weaknesses
- Negative profit margin indicating financial challenges.
- Small market capitalization and OTC listing posing liquidity risks.
- Limited brand recognition compared to larger competitors.
- Dependence on a niche segment of the healthcare IT market.
Catalysts
- Upcoming: Potential partnerships with larger healthcare providers to expand market reach.
- Ongoing: Continued development and enhancement of existing software and hardware solutions.
- Ongoing: Efforts to improve operational efficiency and reduce costs.
Risks
- Potential: Negative profit margin and financial instability.
- Potential: Limited liquidity due to OTC listing.
- Ongoing: Intense competition from larger and more established players.
- Potential: Evolving regulatory requirements and technological advancements.
- Potential: Cybersecurity threats and data privacy concerns.
Growth Opportunities
- Expansion into Telehealth Solutions: Aspyra can leverage its existing expertise in healthcare IT to develop and offer telehealth solutions, capitalizing on the growing demand for remote patient monitoring and virtual consultations. The telehealth market is projected to reach $55.6 billion by 2027, presenting a significant opportunity for Aspyra to diversify its revenue streams and expand its customer base. Timeline: 1-2 years.
- Strategic Partnerships with Healthcare Providers: Aspyra can forge strategic partnerships with hospitals, clinics, and other healthcare providers to integrate its workflow solutions into their existing systems. These partnerships can provide Aspyra with access to a larger customer base and enhance its market visibility. Timeline: Ongoing.
- Development of AI-Powered Diagnostic Tools: Aspyra can invest in the development of artificial intelligence (AI)-powered diagnostic tools to enhance the capabilities of its imaging solutions. AI-powered diagnostics can improve the accuracy and speed of image analysis, leading to better patient outcomes and increased efficiency for healthcare providers. Timeline: 2-3 years.
- Geographic Expansion into Emerging Markets: Aspyra can expand its operations into emerging markets, where there is a growing demand for healthcare IT solutions. These markets offer significant growth potential due to increasing healthcare spending and a lack of established players. Timeline: 3-5 years.
- Focus on Cybersecurity Solutions for Healthcare: With the increasing threat of cyberattacks on healthcare organizations, Aspyra can develop and offer cybersecurity solutions specifically tailored for the healthcare industry. This can help healthcare providers protect sensitive patient data and ensure the integrity of their systems. Timeline: 1-2 years.
Opportunities
- Expansion into telehealth solutions.
- Strategic partnerships with healthcare providers.
- Development of AI-powered diagnostic tools.
- Geographic expansion into emerging markets.
Threats
- Intense competition from larger and more established players.
- Evolving regulatory requirements and technological advancements.
- Cybersecurity threats and data privacy concerns.
- Economic downturns impacting healthcare spending.
Competitive Advantages
- Established presence in the healthcare IT market since 1978.
- Integrated solutions offering a comprehensive approach to healthcare workflows.
- Specialized expertise in laboratory and imaging workflows.
About APYI
Aspyra Inc., established in 1978 and headquartered in Jacksonville, Florida, operates within the healthcare sector, providing a range of products and services tailored for the laboratory and imaging marketplaces. Originally named Creative Computer Applications Inc., the company rebranded as Aspyra Inc. in 2005 to better reflect its focus on integrated healthcare solutions. Aspyra's core offerings include engineered workflow solutions comprising software, interfaces, hardware, and professional services. These solutions are designed to optimize operations for a diverse clientele, including specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. The company's products facilitate efficient data management, streamlined workflows, and enhanced diagnostic capabilities within these healthcare settings. Aspyra's integrated approach aims to improve patient care and operational efficiency for its clients. With a history spanning over four decades, Aspyra has evolved to meet the changing needs of the healthcare industry, focusing on providing comprehensive solutions that address the specific challenges faced by laboratories and imaging centers. The company's commitment to innovation and customer satisfaction has allowed it to maintain a presence in the competitive healthcare IT market.
What They Do
- Provides healthcare products and services for the laboratory and imaging marketplaces.
- Offers engineered workflow solutions that include software.
- Provides hardware solutions for labs and imaging centers.
- Offers professional services to support its products.
- Serves specialty labs, reference labs, clinics, and hospitals.
- Caters to imaging centers and orthopedic practices.
Business Model
- Sells integrated software and hardware solutions to healthcare providers.
- Generates revenue through professional services, including implementation and support.
- Focuses on recurring revenue through software maintenance and upgrades.
Industry Context
Aspyra Inc. operates within the healthcare information services industry, a sector experiencing growth driven by the increasing adoption of digital health solutions and the need for improved efficiency in healthcare workflows. The market is competitive, with established players and emerging startups vying for market share. Aspyra's focus on providing integrated solutions for labs and imaging centers positions it within a niche segment of the broader healthcare IT market. The industry is characterized by evolving regulatory requirements, technological advancements, and a growing emphasis on data security and interoperability.
Key Customers
- Specialty labs
- Reference labs
- Hospitals and clinics
- Imaging centers
- Orthopedic practices
Financials
Chart & Info
Aspyra Inc. (APYI) stock price: Price data unavailable
Latest News
No recent news available for APYI.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for APYI.
Price Targets
Wall Street price target analysis for APYI.
MoonshotScore
What does this score mean?
The MoonshotScore rates APYI's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Gary W. Bennett
CEO
Gary W. Bennett serves as the CEO of Aspyra Inc., leading the company's strategic direction and overseeing its operations. His background includes experience in managing technology-driven businesses and driving growth in the healthcare IT sector. With a focus on innovation and customer satisfaction, Bennett is responsible for guiding Aspyra's efforts to provide integrated workflow solutions for laboratories and imaging centers. His leadership is crucial in navigating the competitive healthcare IT landscape and ensuring the company's long-term success.
Track Record: Under Gary W. Bennett's leadership, Aspyra Inc. has focused on maintaining its position in the healthcare IT market by providing specialized solutions for labs and imaging centers. Key milestones include the continued development and enhancement of the company's software and hardware offerings. His tenure has been marked by efforts to improve operational efficiency and expand the company's customer base.
APYI OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, encompassing stocks that may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, and trading activity can be sporadic. Investing in OTC Other stocks carries a higher degree of risk compared to stocks listed on major exchanges like the NYSE or NASDAQ due to the potential for less transparency and regulatory oversight.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Low trading volume and liquidity.
- Potential for price manipulation and fraud.
- Higher risk of business failure or delisting.
- Limited regulatory oversight and investor protection.
- Verify the company's legal status and registration.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with the OTC Other tier.
- Consult with a qualified financial advisor.
- Check for any regulatory actions or legal proceedings.
- Established presence in the healthcare IT market since 1978.
- Focus on providing specialized solutions for labs and imaging centers.
- Existence of a functional website and contact information.
- Leadership team with relevant industry experience.
- Positive customer testimonials or case studies (if available).
What Investors Ask About Aspyra Inc. (APYI)
What does Aspyra Inc. do?
Aspyra Inc. specializes in providing healthcare IT solutions for the laboratory and imaging marketplaces. The company offers a suite of engineered workflow solutions, including software, hardware, and professional services, designed to streamline operations and improve efficiency for specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. Aspyra's integrated approach aims to enhance data management, workflow optimization, and diagnostic capabilities within these healthcare settings.
What do analysts say about APYI stock?
As of 2026-03-18, there is no readily available analyst coverage for Aspyra Inc. (APYI) due to its listing on the OTC Other tier and small market capitalization. The lack of analyst coverage means that investors must rely on their own research and due diligence to assess the company's prospects and valuation. Key metrics to consider include the company's financial performance, growth potential, and competitive positioning within the healthcare IT market.
What are the main risks for APYI?
Aspyra Inc. faces several risks, including its negative profit margin, which raises concerns about its financial sustainability. The company's OTC listing and small market capitalization pose liquidity risks and increase the potential for price volatility. Aspyra also faces intense competition from larger and more established players in the healthcare IT market. Additionally, evolving regulatory requirements, technological advancements, and cybersecurity threats present ongoing challenges for the company.
What are the key factors to evaluate for APYI?
Aspyra Inc. (APYI) currently holds an AI score of 52/100, indicating moderate score. Key strength: Long-standing presence in the healthcare IT market.. Primary risk to monitor: Potential: Negative profit margin and financial instability.. This is not financial advice.
How frequently does APYI data refresh on this page?
APYI prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven APYI's recent stock price performance?
Recent price movement in Aspyra Inc. (APYI) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Long-standing presence in the healthcare IT market.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider APYI overvalued or undervalued right now?
Determining whether Aspyra Inc. (APYI) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying APYI?
Before investing in Aspyra Inc. (APYI), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial information available due to OTC listing.
- AI analysis pending for APYI.